Declining Inpatient Mortality Despite Increasing Thirty-Day Readmissions of Alcoholic Hepatitis in the United States From 2010 to 2018.
Alcoholic hepatitis
Hepatitis
Mortality
Outcomes
Trends
Journal
Gastroenterology research
ISSN: 1918-2805
Titre abrégé: Gastroenterology Res
Pays: Canada
ID NLM: 101519422
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
13
10
2021
accepted:
11
11
2021
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
22
1
2022
Statut:
ppublish
Résumé
Alcoholic hepatitis (AH) readmissions are commonly secondary to relapse to alcohol use after discharge from the hospital. This retrospective interrupted trend study analyzed the National Readmissions Database (NRD) from 2010 to 2018 to identify 30-day readmissions of AH using the International Classification of Diseases (ICD)-9 and ICD-10 codes (571.1 and K70.1). Individuals < 18 years, elective and traumatic readmissions were excluded. The biodemographic characteristics and hospitalization trends were highlighted over an 8-year time frame. A multivariate regression analysis was used to calculate the risk-adjusted odds of trends for all-cause 30-day readmissions, AH-specific readmissions, inpatient mortality, mean length of stay (LOS), and mean total hospital charge (THC) after adjusting for age, gender, grouped Charlson Comorbidity Index (CCI), type of insurance, mean household income, and hospital characteristics. P-values ≤ 0.05 were considered statistically significant. We noted an increasing trend for total 30-day readmissions of AH from 1,839 in 2010 to 3,784 in 2018 (P-trend < 0.001). Males made up a majority of the population; however, gender distribution was not statistically significant. Additionally, 30-day AH readmissions had an increasing comorbidity burden with time. The 30-day all-cause readmission rate increased from 18.8% in 2010 to 24.4% in 2018 and AH-specific readmission rate from 2.9% in 2010 to 3.9% in 2018 without a statistically significant trend. However, we noted a declining risk-adjusted trend of inpatient mortality for 30-day readmissions of AH from 8.7% in 2010 to 7.4% in 2018 (P-trend = 0.022). Furthermore, the total LOS attributable to 30-day readmissions of AH increased by 132.5% from 11,275 days in 2010 to 26,220 days in 2018 and the attributable THC increased by 160.9% to over $67 million in 2018. For 30-day AH readmissions, inpatient mortality declined to 7.4% in 2018, while the total number of hospitalizations, LOS and THC increased from 2010 to 2018.
Sections du résumé
BACKGROUND
BACKGROUND
Alcoholic hepatitis (AH) readmissions are commonly secondary to relapse to alcohol use after discharge from the hospital.
METHODS
METHODS
This retrospective interrupted trend study analyzed the National Readmissions Database (NRD) from 2010 to 2018 to identify 30-day readmissions of AH using the International Classification of Diseases (ICD)-9 and ICD-10 codes (571.1 and K70.1). Individuals < 18 years, elective and traumatic readmissions were excluded. The biodemographic characteristics and hospitalization trends were highlighted over an 8-year time frame. A multivariate regression analysis was used to calculate the risk-adjusted odds of trends for all-cause 30-day readmissions, AH-specific readmissions, inpatient mortality, mean length of stay (LOS), and mean total hospital charge (THC) after adjusting for age, gender, grouped Charlson Comorbidity Index (CCI), type of insurance, mean household income, and hospital characteristics. P-values ≤ 0.05 were considered statistically significant.
RESULTS
RESULTS
We noted an increasing trend for total 30-day readmissions of AH from 1,839 in 2010 to 3,784 in 2018 (P-trend < 0.001). Males made up a majority of the population; however, gender distribution was not statistically significant. Additionally, 30-day AH readmissions had an increasing comorbidity burden with time. The 30-day all-cause readmission rate increased from 18.8% in 2010 to 24.4% in 2018 and AH-specific readmission rate from 2.9% in 2010 to 3.9% in 2018 without a statistically significant trend. However, we noted a declining risk-adjusted trend of inpatient mortality for 30-day readmissions of AH from 8.7% in 2010 to 7.4% in 2018 (P-trend = 0.022). Furthermore, the total LOS attributable to 30-day readmissions of AH increased by 132.5% from 11,275 days in 2010 to 26,220 days in 2018 and the attributable THC increased by 160.9% to over $67 million in 2018.
CONCLUSIONS
CONCLUSIONS
For 30-day AH readmissions, inpatient mortality declined to 7.4% in 2018, while the total number of hospitalizations, LOS and THC increased from 2010 to 2018.
Identifiants
pubmed: 35059067
doi: 10.14740/gr1473
pmc: PMC8734495
doi:
Types de publication
Journal Article
Langues
eng
Pagination
334-339Informations de copyright
Copyright 2021, Dahiya et al.
Déclaration de conflit d'intérêts
The authors report no conflict of interest.
Références
Hepat Med. 2019 Aug 08;11:97-108
pubmed: 31496843
Alcohol Res. 2017;38(2):147-161
pubmed: 28988570
PLoS One. 2018 Feb 14;13(2):e0192393
pubmed: 29444123
Lancet Gastroenterol Hepatol. 2020 May;5(5):494-506
pubmed: 32277902
Gastroenterology. 2016 Jun;150(8):1786-97
pubmed: 26924091
Health Serv Res. 2018 Feb;53(1):175-196
pubmed: 27873305
Alcohol Clin Exp Res. 2018 Feb;42(2):352-359
pubmed: 29293274
Dig Dis Sci. 2020 Apr;65(4):990-1002
pubmed: 31372912
Hepatology. 2017 Nov;66(5):1464-1473
pubmed: 28459138
Clin Gastroenterol Hepatol. 2020 Feb;18(2):477-485.e5
pubmed: 31042580
Med Care. 2007 Dec;45(12):1210-5
pubmed: 18007172
Hepatology. 2017 Dec;66(6):1842-1853
pubmed: 28646515
Int J Environ Res Public Health. 2018 May 28;15(6):
pubmed: 29843384
World J Hepatol. 2011 May 27;3(5):108-13
pubmed: 21731902